• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

TEO Removal from Official List04/01/16
TEO Ceasing to be a substantial holder30/07/15
TEO Initial Director's Interest Notices29/06/15
TEO Final Director's Interest Notices25/06/15
TEO Director Appointment/Resignation22/06/15
TEO Becoming a substantial holder07/07/14
TEO Ceasing to be a substantial holder07/07/14
TEOAppendix 3Y Query and Response24/01/14
TEOBecoming a substantial shareholder23/01/14
TEOBecoming a substantial holder23/01/14
TEOAppendix 3Y22/01/14
TEOCeasing to be a substantial holder10/01/14
TEOAppendix 3X - Michael Young02/01/14
TEOAppendix 3X - Robert Parton02/01/14
TEOAppendix 3X - Samuel Armytage02/01/14
TEOCompany Officer Changes18/11/13
TEOShare Consolidation06/11/13
TEODirector Appointment/Resignation & Appendix 3Z01/11/13
TEOMimetica Acquisition Update22/10/13
TEOTelesso Announces Supplementary Prospectus27/09/13
TEOAnnual Report to shareholders25/09/13
TEOTelesso Launches Prospectus02/09/13
TEOResults of Meeting29/08/13
TEOIndicative Share Consolidation Timetable28/08/13
TEOAppendix 4E27/08/13
TEOCapital Raising Prospectus20/08/13
TEOProspectus08/08/13
TEOProspectus Lodged with ASIC07/08/13
TEONotice of General Meeting31/07/13
TEOLetter to Shareholders21/06/13
TEOTELESSO TO ACQUIRE DERMATOLOGY COMPANY15/04/13
TEOHalf Yearly Report and Accounts27/02/13
TEOSuspension Request04/02/13
TEOResults of Meeting22/01/13
TEONotice of Annual General Meeting21/12/12
TEOSuspension from official quotationPRICE SENSITIVE17/12/12
TEODirector Appointment/Resignation09/10/12
TEOAppendix 4EPRICE SENSITIVE30/08/12
TEOHalf Yearly Report and AccountsPRICE SENSITIVE28/02/12
TEOResults of Meeting08/11/11
TEONotice of Annual General Meeting/Proxy Form05/10/11
TEOAppendix 4E June 2011PRICE SENSITIVE30/08/11
TEODetails of Company Address08/06/11
TEOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/11
TEOTelesso Securities Trading Policy21/01/11
TEOBoard Changes23/12/10
TEOVPI Capital RaisingPRICE SENSITIVE10/12/10
TEOResults of Meeting25/11/10
TEONotice of Annual General Meeting/Proxy Form18/10/10
TEOAnnual Report to shareholders18/10/10
TEOPreliminary Final ReportPRICE SENSITIVE30/08/10
TEOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/10
TEOResults of Meeting28/10/09
TEOTelesso Signs MOUPRICE SENSITIVE21/10/09
TEONotice of Annual General Meeting/Proxy Form08/10/09
TEOAnnual Report to shareholders22/09/09
TEOPreliminary Final ReportPRICE SENSITIVE31/08/09
TEOClinical Trial UpdatePRICE SENSITIVE24/06/09
TEOChange of Registered Office05/06/09
TEOTechnology Wins Popular Science Award13/05/09
TEOVPI Clinical TrialPRICE SENSITIVE23/04/09
TEOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/09
TEOMAP Payment19/01/09
TEOClinical Trial with Vascular PathwaysPRICE SENSITIVE08/12/08
TEOStrategic Clinical TrialPRICE SENSITIVE05/12/08
TEO Removal from Official List
04/01/16
TEO Ceasing to be a substantial holder
30/07/15
TEO Initial Director's Interest Notices
29/06/15
TEO Final Director's Interest Notices
25/06/15
TEO Director Appointment/Resignation
22/06/15
TEO Becoming a substantial holder
07/07/14
TEO Ceasing to be a substantial holder
07/07/14
TEOAppendix 3Y Query and Response
24/01/14
TEOBecoming a substantial shareholder
23/01/14
TEOBecoming a substantial holder
23/01/14
TEOAppendix 3Y
22/01/14
TEOCeasing to be a substantial holder
10/01/14
TEOAppendix 3X - Michael Young
02/01/14
TEOAppendix 3X - Robert Parton
02/01/14
TEOAppendix 3X - Samuel Armytage
02/01/14
TEOCompany Officer Changes
18/11/13
TEOShare Consolidation
06/11/13
TEODirector Appointment/Resignation & Appendix 3Z
01/11/13
TEOMimetica Acquisition Update
22/10/13
TEOTelesso Announces Supplementary Prospectus
27/09/13
TEOAnnual Report to shareholders
25/09/13
TEOTelesso Launches Prospectus
02/09/13
TEOResults of Meeting
29/08/13
TEOIndicative Share Consolidation Timetable
28/08/13
TEOAppendix 4E
27/08/13
TEOCapital Raising Prospectus
20/08/13
TEOProspectus
08/08/13
TEOProspectus Lodged with ASIC
07/08/13
TEONotice of General Meeting
31/07/13
TEOLetter to Shareholders
21/06/13
TEOTELESSO TO ACQUIRE DERMATOLOGY COMPANY
15/04/13
TEOHalf Yearly Report and Accounts
27/02/13
TEOSuspension Request
04/02/13
TEOResults of Meeting
22/01/13
TEONotice of Annual General Meeting
21/12/12
TEOSuspension from official quotation
17/12/12PRICE SENSITIVE
TEODirector Appointment/Resignation
09/10/12
TEOAppendix 4E
30/08/12PRICE SENSITIVE
TEOHalf Yearly Report and Accounts
28/02/12PRICE SENSITIVE
TEOResults of Meeting
08/11/11
TEONotice of Annual General Meeting/Proxy Form
05/10/11
TEOAppendix 4E June 2011
30/08/11PRICE SENSITIVE
TEODetails of Company Address
08/06/11
TEOHalf Yearly Report and Accounts
25/02/11PRICE SENSITIVE
TEOTelesso Securities Trading Policy
21/01/11
TEOBoard Changes
23/12/10
TEOVPI Capital Raising
10/12/10PRICE SENSITIVE
TEOResults of Meeting
25/11/10
TEONotice of Annual General Meeting/Proxy Form
18/10/10
TEOAnnual Report to shareholders
18/10/10
TEOPreliminary Final Report
30/08/10PRICE SENSITIVE
TEOHalf Yearly Report and Accounts
25/02/10PRICE SENSITIVE
TEOResults of Meeting
28/10/09
TEOTelesso Signs MOU
21/10/09PRICE SENSITIVE
TEONotice of Annual General Meeting/Proxy Form
08/10/09
TEOAnnual Report to shareholders
22/09/09
TEOPreliminary Final Report
31/08/09PRICE SENSITIVE
TEOClinical Trial Update
24/06/09PRICE SENSITIVE
TEOChange of Registered Office
05/06/09
TEOTechnology Wins Popular Science Award
13/05/09
TEOVPI Clinical Trial
23/04/09PRICE SENSITIVE
TEOHalf Yearly Report and Accounts
25/02/09PRICE SENSITIVE
TEOMAP Payment
19/01/09
TEOClinical Trial with Vascular Pathways
08/12/08PRICE SENSITIVE
TEOStrategic Clinical Trial
05/12/08PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.